SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-029660
Filing Date
2023-11-01
Accepted
2023-11-01 07:33:29
Documents
14
Period of Report
2023-11-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tgtx20231030_8k.htm   iXBRL 8-K 23597
2 EXHIBIT 99.1 ex_587872.htm EX-99.1 125980
  Complete submission text file 0001437749-23-029660.txt   297913

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20231101.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20231101_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20231101_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20231101_pre.xml EX-101.PRE 11585
8 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20231030_8k_htm.xml XML 2573
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 231366577
SIC: 2834 Pharmaceutical Preparations